Hematologist
CION Cancer Clinics
Blastic plasmacytoid dendritic cell neoplasm, explained | CION Cancer Clinics
BPDCN is a rare, fast-growing blood cancer that very often first appears as bruise-like purple or brown patches on the skin, and usually also affects the bone marrow, blood and lymph nodes. It is confirmed with a skin biopsy, marker tests and a marrow biopsy. Treatment is planned by a haematologist and may include a targeted medicine, intensive chemotherapy or a transplant. This page explains each step. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
The short answer
What is BPDCN?
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and fast-growing blood cancer. It very often shows up first as bruise-like purple or brown patches or lumps on the skin, and it usually also affects the bone marrow, blood and lymph nodes.
The cell it starts in
Plasmacytoid dendritic cells are immune cells that normally help the body respond to viruses. In BPDCN, an early form of these cells becomes cancerous and multiplies. Because the cancer cells are immature, doctors call them blasts, the same word used in acute leukaemia.
Who it affects
It is most often found in older adults, more commonly in men, though it can occur at any age, including in children. It is rare enough that many doctors will see only a few cases in their career. That is one reason diagnosis can take time.
Why it matters to act promptly
BPDCN usually grows quickly. Skin patches may be the only sign at first, but the marrow is often involved already or becomes involved soon. A skin patch that looks like a bruise but does not fade, spreads or forms a lump is worth showing to a doctor without delay, particularly if it comes with tiredness, fevers or easy bleeding.
Most bruise-like patches have ordinary causes. This page does not mean a patch on your skin is BPDCN.Signs and symptoms
Where in the body does BPDCN show itself?
Skin
Purple, reddish-brown or bruise-coloured patches, plaques or lumps. They may be single or many, and are usually not itchy or painful. They can appear anywhere, including the face, scalp, chest and legs.
Worth noting
- Whether they appeared without an injury
- Whether they are growing or multiplying
Bone marrow and blood
Low haemoglobin, a low platelet count and changes in the white cells. This causes tiredness, breathlessness, easy bruising, bleeding gums and infections.
Lymph nodes and spleen
Swollen glands in the neck, armpit or groin, and sometimes an enlarged spleen causing fullness under the left ribs. Some people also notice fevers, night sweats or weight loss they cannot explain.
Brain and spinal fluid
Less common, but it can spread to the fluid around the brain, sometimes without symptoms. It is checked for even when you feel well.
This is why a lumbar puncture is often part of the tests.Not sure whether this applies to you?
Ask an oncologistGetting a diagnosis
Which tests confirm BPDCN?
-
Skin biopsy
A small piece of an affected patch is removed under local anaesthetic and examined. This is often where the diagnosis is first suspected.
-
Immunohistochemistry and flow cytometry
These tests stain or read markers on the cancer cells. BPDCN has a typical combination of markers, and that combination is what separates it from acute leukaemia and skin lymphoma.
-
Bone marrow biopsy and blood tests
A marrow sample shows whether the marrow is involved. Blood tests check counts, kidneys and liver.
-
Scans and a lumbar puncture
A PET-CT or CT scan looks for affected lymph nodes and organs. A lumbar puncture checks the spinal fluid.
-
Review by a specialist team
Because BPDCN is rare, reports are often reviewed by a pathologist with experience of the disease, and the case discussed at a tumour board before treatment is planned.
On your report
What do the markers on the report mean?
- CD123
- A marker found strongly on BPDCN cells. It matters because one targeted medicine is aimed at it.
- CD4 and CD56
- Two surface markers that, together with CD123, make up the typical pattern.
- TCF4, TCL1 and CD303
- Further markers that help the pathologist confirm the diagnosis and rule out look-alike cancers.
- Blasts
- Immature cancer cells. Their presence in the marrow or blood shows the marrow is involved.
- CNS involvement
- Cancer cells found in the fluid around the brain and spinal cord.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What treatment approaches are used?
Approach
Who it is usually considered for
Tagraxofusp, a targeted medicine aimed at CD123
Many adults, including some older patients, with close monitoring
Intensive chemotherapy, similar to acute leukaemia treatment
Fitter patients able to manage a hospital stay and low counts
Stem cell transplant after a response
Selected fitter patients, arranged at a transplant centre
Gentler treatment and supportive care
People for whom intensive treatment would do more harm than good
Commonly believed
What do families often get wrong about BPDCN?
"It started on the skin, so a skin doctor can treat it."
BPDCN is a blood cancer even when the skin is all you can see. It needs a haematologist, because the marrow and other organs are often involved or soon will be. Removing a skin patch alone does not treat it.
"The patches are only bruises from a fall."
Ordinary bruises change colour and fade over a couple of weeks. Patches that stay, grow, become raised or keep appearing without injury should be shown to a doctor.
"At his age, there is nothing to be done."
Age alone does not decide it. Some older patients are suitable for targeted treatment, and supportive care can control symptoms well. Ask the haematologist what is possible for him in particular.
"A second opinion will waste precious time."
For a rare cancer, a pathology review by an experienced team is often part of getting the diagnosis right. It can usually run alongside planning rather than delaying it.
Being straight with you
What can this page not tell you?
This page cannot tell you which treatment suits you, or what to expect. BPDCN is serious, and the outlook depends on your age, your fitness, how far it has spread and how it responds to the first treatment. Ask your haematologist to explain what your results mean for you.
Who intensive treatment does not suit
Intensive chemotherapy and transplant carry real risks. They are usually not suitable for people with serious heart, lung or kidney disease, or who are very frail. The targeted medicine also has its own side effects, including fluid build-up and liver changes, and needs close monitoring in the first weeks.
What CION does, and what it arranges
CION's haematology team reviews your reports, presents your case at a tumour board and plans treatment with you. CION does not perform stem cell transplants. Where a transplant or a specialised test is needed, the team coordinates it with qualified centres. Ask early whether a transplant is a possibility, since the search for a donor takes time.
Bring every biopsy report and slide or block number you have. A second review of the same tissue is often possible without another biopsy.Questions we are asked
Common questions about BPDCN
Is BPDCN a leukaemia or a lymphoma?
Neither exactly. It is its own type of blood cancer, classed with the myeloid blood cancers. It was once called other names, including blastic NK-cell lymphoma, and it is often treated in a similar way to acute leukaemia. Older reports may use those earlier names.
Is BPDCN inherited, or did we cause it?
It is not known to run in families, and nothing you ate, did or failed to do has been shown to cause it. The gene changes happen in the cells during life. Children and siblings do not need testing because of your diagnosis.
Will the skin patches go away with treatment?
They often shrink or fade when treatment works. Your team watches the skin, the blood and the marrow together to judge the response. New patches during or after treatment should be reported straight away, because they can be an early sign of the cancer returning.
Does treatment need a hospital stay?
Usually yes, at least at the start. Intensive chemotherapy needs admission, and the targeted medicine is usually started in hospital so side effects such as fluid build-up can be watched closely. Later treatment may be given as a day-care patient.
What should we do if a fever starts during treatment?
Treat it as an emergency. Low white cell counts make infections dangerous quickly. Go to the nearest emergency department the same day or call 108, and say the person is being treated for a blood cancer. Also report sudden weight gain or swelling, which can be a medicine side effect.
Can a child get BPDCN?
It is uncommon in children but it does occur. Children are usually treated by a paediatric haematology team, and the approach may differ from adults. The diagnosis still needs the same careful biopsy and marker tests.
Why do doctors talk about a transplant so early?
For fitter patients who respond to the first treatment, a stem cell transplant may be considered to lower the chance of the cancer coming back. Finding a matched donor and a transplant centre takes time, so the conversation often starts early, even if it is not the final choice.
Is treatment covered by schemes or insurance?
Blood cancer treatment is often covered by Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance, but newer targeted medicines and transplants may not be fully covered. Scheme rules change. Share your card details with the helpline and ask the team to check your current cover.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Blastic plasmacytoid dendritic cell neoplasm - NCI Dictionary of Cancer Terms
- Leukemia & Lymphoma Society — Leukemia
- American Society of Hematology — Blood Cancers
- National Health Mission — National Health Mission
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Facing a BPDCN diagnosis?
Share the biopsy and blood reports with us. CION's haematology team will review them and help plan the next steps. One helpline serves every CION centre.